Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

OrthoLogic initiates phase I/II trial of Chrysalin for accelerated tissue repair

Jan. 14, 2000

Corixa to commence phase II trials of PVAC for treatment of psoriasis

Jan. 13, 2000

Alexion files IND for C5 inhibitor trial in psoriasis patients

Jan. 13, 2000

Positive preclinical results reported for Maxim's oral mucositis gel

Jan. 12, 2000

Japanese patent covers new selectin inhibitors useful for inflammatory conditions

Jan. 11, 2000

Results of interim review support continuation of phase II study evaluating P45

Jan. 11, 2000

Connetics expands dermatology pipeline

Dec. 30, 1999

Janssen group presents preparation, activity and use of new PDE4/TNF-alpha inhibitors

Dec. 28, 1999

Biomatrix receives go-ahead to test product for preventing lumbar postsurgical adhesions

Dec. 28, 1999

Organogenesis seeks FDA approval of Apligraf for diabetic foot ulcers

Dec. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...